Document Classification

Section Type: RESULTS

Text: The overall incidence of IFI was 32/175 (18. 3 %) [10/175 (5. 7 %) probable/proven and 22/175 (12. 6 %) possible], with no statistically significant differences between caspofungin-based versus SP-based regimens [overall : 15/93 (16. 1 %) versus 17/82 (20. 7 %), relative risk (RR) 0. 78, 95 % confidence interval (CI) 0. 42-1. 46 ; probable/proven : 7/93 (7. 5 %) versus 3/82 (3. 7 %), RR 2. 06, 95 % CI 0. 55-7. 7 ; possible : 8/93 (8. 6 %) versus 14/82 (17. 1 %), RR 0. 5, 95 % CI 0. 22-1. 14].